Atlas Trials

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

Clinical trial NCT00486538 · COMPLETED

Trial details

NCT number
NCT00486538
Sponsor
AbbVie (prior sponsor, Abbott)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Renal Cell Carcinoma
Start date
2007-06-01
Primary completion
2011-06-01
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.